Hans Garmo

21PUBLICATIONS
38CO-AUTHORS
MortalityPredictive and prognostic markersEpidemiological modellingCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Dec 26, 2025
Optimised comorbidity indices can reflect patient performance status in register based studies of prostate cancer.

Marcus Westerberg, Hans Garmo, Jesper Bonnedahl

|Oct 13, 2025
Radium-223 use and survival by line of treatment in metastatic castration-resistant prostate cancer: a nationwide population-based register study.

Charlotte Alverbratt, Fredrik Sandin, Viktor Kolmbäck

|Jul 01, 2025
Family History of Early Onset or Lethal Prostate Cancer and the Risk of Prostate Cancer Death in Sweden.

E Lin, Hans Garmo, Kerri Beckmann

Pageof 4